We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+13.78%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.8B
AUM Growth
+$1.68B
(+11%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
18.74%
Holding
1,305
New
129
Increased
549
Reduced
440
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$101M |
| 2 |
Texas Instruments
TXN
|
+$84.9M |
| 3 |
TSMC
TSM
|
+$77.7M |
| 4 |
Cisco
CSCO
|
+$59.3M |
| 5 |
NextEra Energy
NEE
|
+$49.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$840M |
| 2 |
Procter & Gamble
PG
|
+$95.7M |
| 3 |
Alibaba
BABA
|
+$57.3M |
| 4 |
Merck
MRK
|
+$49.9M |
| 5 |
Target
TGT
|
+$40.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 16.73% |
| 3 | Financials | 14.72% |
| 4 | Communication Services | 9.74% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Regal Rexnord
RRX
$11.7B
| $443K | ﹤0.01% |
5,278
-22
| -0.4% | -$1.74K |
|
|
AMED
927
DELISTED
Amedisys
AMED
| $441K | ﹤0.01% |
3,600
+2,600
| +260% | +$326K |
|
928
Ironwood Pharmaceuticals
IRWD
$673M
| $440K | ﹤0.01% |
27,411
-79,484
| -74% | -$888K |
|
|
NOAH
929
Noah Holdings
NOAH
$605M
| $436K | ﹤0.01% |
1,011
-40
| -4% | -$1.94K |
|
930
Kimco Realty
KIM
$16.1B
| $434K | ﹤0.01% |
23,400
+2,369
| +11% | +$40.7K |
|
|
ALDR
931
DELISTED
Alder Biopharmaceuticals
ALDR
| $432K | ﹤0.01% |
24,200
+4,400
| +22% | +$57K |
|
932
Coherus Oncology
CHRS
$198M
| $426K | ﹤0.01% |
21,300
+3,600
| +20% | +$48K |
|
933
Interface
TILE
$2.19B
| $426K | ﹤0.01% |
+18,214
| New | +$298K |
|
|
WCC
934
WESCO International
WCC
$18B
| $426K | ﹤0.01% |
+7,008
| New | +$371K |
|
935
Zillow
Z
$7.47B
| $423K | ﹤0.01% |
8,228
+1,752
| +27% | +$62.5K |
|
|
AIMT
936
DELISTED
Aimmune Therapeutics
AIMT
| $423K | ﹤0.01% |
15,100
+2,700
| +22% | +$63.6K |
|
937
Karyopharm Therapeutics
KPTI
$44.4M
| $419K | ﹤0.01% |
1,320
+227
| +21% | +$25.2K |
|
|
BOLD
938
DELISTED
Audentes Therapeutics, Inc
BOLD
| $418K | ﹤0.01% |
11,500
+2,100
| +22% | +$60.2K |
|
|
AAN.A
939
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $417K | ﹤0.01% |
8,471
+5,348
| +171% | +$263K |
|
|
FLG
940
Flagstar Bank National Association
FLG
$5.82B
| $415K | ﹤0.01% |
+12,053
| New | +$415K |
|
|
GHDX
941
DELISTED
Genomic Health, Inc.
GHDX
| $413K | ﹤0.01% |
6,800
+3,300
| +94% | +$245K |
|
942
KB Financial Group
KB
$42.4B
| $411K | ﹤0.01% |
9,202
| – | – |
|
943
Silicon Laboratories
SLAB
$7.2B
| $411K | ﹤0.01% |
4,200
-850
| -17% | -$70.7K |
|
|
CKH
944
DELISTED
Seacor Holdings Inc.
CKH
| $409K | ﹤0.01% |
+7,958
| New | +$339K |
|
|
NAV
945
DELISTED
Navistar International
NAV
| $408K | ﹤0.01% |
9,440
| – | – |
|
946
Assurant
AIZ
$14.2B
| $406K | ﹤0.01% |
3,711
-368
| -9% | -$35.6K |
|
947
NNN REIT
NNN
$8.81B
| $404K | ﹤0.01% |
8,048
+85
| +1% | +$4.41K |
|
|
TLRD
948
DELISTED
Tailored Brands, Inc.
TLRD
| $401K | ﹤0.01% |
17,700
+1,600
| +10% | +$18.9K |
|
949
Wipro
WIT
$19.8B
| $399K | ﹤0.01% |
155,864
-51,955
| -25% | -$106K |
|
950
Ovintiv
OVV
$17.5B
| $398K | ﹤0.01% |
5,967
-4,806
| -45% | -$165K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q1 2019 Portfolio in Review
As of Q1 2019, DekaBank Deutsche Girozentrale held 1,305 positions worth $16.8B, up 11% from $15.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $601M in Q1 2019, closing 115 positions and reducing 440 holdings. Its most notable exit was Linde, an estimated $840M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in Express Scripts Holding Company worth $46.5M.
- DekaBank Deutsche Girozentrale's largest Q1 2019 buy was Express Scripts Holding Company: 521,657 shares worth $46.5M.
- DekaBank Deutsche Girozentrale added most to Johnson & Johnson in Q1 2019, an estimated $101M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2019 reduction was Procter & Gamble, cutting an estimated $95.7M.
- DekaBank Deutsche Girozentrale fully exited Linde in Q1 2019, selling an estimated $840M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.8B portfolio in Q1 2019.
- DekaBank Deutsche Girozentrale opened 129 new positions and closed 115 in Q1 2019.
- DekaBank Deutsche Girozentrale's portfolio value rose 11% quarter-over-quarter to $16.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2019, filed 10 May 2019.